Economic Observation Network Maipu Medical's acquisition of loss making assets under the actual controller at a premium of 2.6 times has raised concerns in the market about its profit impact after the relevant matters are resolved.

Progress of related party transactions:
The matter of the company's acquisition of the loss making asset "Yijie Medical" under the actual controller at a premium of 2.6 times was discussed at the meeting on the evening of the 26th This belongs to the category of 'all the good news coming out', and the feasibility of the target company's continuous losses (net loss of 12.45 million yuan in the first 11 months of 2025) and performance commitments (still losses in 2026) has been questioned by regulatory authorities The market voted with its feet, expressing concerns about whether this related party transaction can truly increase the company's profits.

The above content is based on publicly available information and does not constitute investment advice.